{
    "PMC5564609_3": [
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Delayed gastric emptying",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence, P]",
            "outcomes": "[15, 0.02]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Delayed gastric emptying",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence, P]",
            "outcomes": "[32, 0.02]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Bleeding",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence, P]",
            "outcomes": "[6, 0.5]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Bleeding",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence, P]",
            "outcomes": "[4, 0.5]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Pancreatic fistula",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence, P]",
            "outcomes": "[39, 0.52]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Pancreatic fistula",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence, P]",
            "outcomes": "[36, 0.52]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Pancreatic fistula Grade A",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence]",
            "outcomes": "[8]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Pancreatic fistula Grade A",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Pancreatic fistula Grade B",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence]",
            "outcomes": "[10]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Pancreatic fistula Grade B",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Pancreatic fistula Grade C",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence]",
            "outcomes": "[21]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Pancreatic fistula Grade C",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence]",
            "outcomes": "[24]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Biliary fistula",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence, P]",
            "outcomes": "[2, 0.47]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Biliary fistula",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence, P]",
            "outcomes": "[0, 0.47]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Wound infection",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence, P]",
            "outcomes": "[5, 0.66]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Wound infection",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence, P]",
            "outcomes": "[3, 0.66]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Pulmonary complication",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence, P]",
            "outcomes": "[2, 0.1]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Pulmonary complication",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence, P]",
            "outcomes": "[4, 0.1]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Skin orifice infection",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence, P]",
            "outcomes": "[1, 0.012]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Skin orifice infection",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence, P]",
            "outcomes": "[6, 0.012]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Abdominal abscess",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Abdominal abscess",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Pancreatitis",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence, P]",
            "outcomes": "[2, 1]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Pancreatitis",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence, P]",
            "outcomes": "[1, 1]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Sepsis",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence, P]",
            "outcomes": "[1, 1]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Sepsis",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence, P]",
            "outcomes": "[0, 1]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Re-laparotomy",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence, P]",
            "outcomes": "[3, 0.6]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Re-laparotomy",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence, P]",
            "outcomes": "[1, 0.6]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Mortality",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Mortality",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Readmission (in 30 days)",
                "group": "ERAS",
                "n": "76"
            },
            "measures": "[incidence, P]",
            "outcomes": "[1, 1]"
        },
        {
            "subject": {
                "study type": "post-operative complications and mortalities",
                "groups": "ERAS and Conventional",
                "statistical test": "Fisher exact test",
                "parameter": "Readmission (in 30 days)",
                "group": "Conventional",
                "n": "83"
            },
            "measures": "[incidence, P]",
            "outcomes": "[1, 1]"
        }
    ],
    "PMC3798558_1": [
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "age": "<40"
            },
            "measures": "[percentage, P]",
            "outcomes": "[5.41, 0.999]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "age": "\u226540 but <50"
            },
            "measures": "[percentage, P]",
            "outcomes": "[10.27, 0.999]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "age": "\u226550 but <60"
            },
            "measures": "[percentage, P]",
            "outcomes": "[32.43, 0.999]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "age": "\u226560 but <70"
            },
            "measures": "[percentage, P]",
            "outcomes": "[32.43, 0.999]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "age": "\u226570"
            },
            "measures": "[percentage, P]",
            "outcomes": "[19.46, 0.999]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "sex": "male"
            },
            "measures": "[percentage, P]",
            "outcomes": "[68.65, 0.068]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "sex": "female"
            },
            "measures": "[percentage, P]",
            "outcomes": "[31.35, 0.068]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "current BMI": "<18.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[8.11, 0.021]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "current BMI": "\u226518.5 but <22.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[45.11, 0.021]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "current BMI": "\u226522.5 but <25"
            },
            "measures": "[percentage, P]",
            "outcomes": "[25.41, 0.021]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "current BMI": "\u226525 but <27.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[13.51, 0.021]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "current BMI": "\u226527.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[7.57, 0.021]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "current BMI": "unknown"
            },
            "measures": "[percentage, P]",
            "outcomes": "[0.00, 0.021]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "BMI at age 20": "<18.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[7.57, 0.018]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "BMI at age 20": "\u226518.5 but <22.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[60.54, 0.018]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "BMI at age 20": "\u226522.5 but <25"
            },
            "measures": "[percentage, P]",
            "outcomes": "[19.46, 0.018]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "BMI at age 20": "\u226525 but <27.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[5.95, 0.018]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "BMI at age 20": "\u226527.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[3.24, 0.018]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "BMI at age 20": "unknown"
            },
            "measures": "[percentage, P]",
            "outcomes": "[3.24, 0.018]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "cigarette pack-years": "<5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[37.30, 0.005]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "cigarette pack-years": "\u22655 but <20"
            },
            "measures": "[percentage, P]",
            "outcomes": "[11.89, 0.005]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "cigarette pack-years": "\u226520 but <40"
            },
            "measures": "[percentage, P]",
            "outcomes": "[18.38, 0.005]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "cigarette pack-years": "\u226540"
            },
            "measures": "[percentage, P]",
            "outcomes": "[32.43, 0.005]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "cigarette pack-years": "unknown"
            },
            "measures": "[percentage, P]",
            "outcomes": "[0.00, 0.005]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "drinking": "non"
            },
            "measures": "[percentage, P]",
            "outcomes": "[30.27, 0.568]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "drinking": "<23"
            },
            "measures": "[percentage, P]",
            "outcomes": "[28.65, 0.568]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "drinking": "\u226523 but <46"
            },
            "measures": "[percentage, P]",
            "outcomes": "[23.24, 0.568]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "drinking": "\u226546"
            },
            "measures": "[percentage, P]",
            "outcomes": "[16.76, 0.568]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "drinking": "unknown"
            },
            "measures": "[percentage, P]",
            "outcomes": "[1.08, 0.568]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "history of diabetes mellitus": "yes"
            },
            "measures": "[percentage, P]",
            "outcomes": "[20.00, <0.001]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "history of diabetes mellitus": "no"
            },
            "measures": "[percentage, P]",
            "outcomes": "[80.00, <0.001]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "family history of PC": "yes"
            },
            "measures": "[percentage, P]",
            "outcomes": "[4.32, 0.811]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "cases",
                "family history of PC": "no"
            },
            "measures": "[percentage, P]",
            "outcomes": "[95.68, 0.811]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "age": "<40"
            },
            "measures": "[percentage, P]",
            "outcomes": "[5.12, 0.999]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "age": "\u226540 but <50"
            },
            "measures": "[percentage, P]",
            "outcomes": "[10.03, 0.999]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "age": "\u226550 but <60"
            },
            "measures": "[percentage, P]",
            "outcomes": "[32.70, 0.999]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "age": "\u226560 but <70"
            },
            "measures": "[percentage, P]",
            "outcomes": "[33.04, 0.999]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "age": "\u226570"
            },
            "measures": "[percentage, P]",
            "outcomes": "[19.11, 0.999]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "sex": "male"
            },
            "measures": "[percentage, P]",
            "outcomes": "[74.88, 0.068]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "sex": "female"
            },
            "measures": "[percentage, P]",
            "outcomes": "[25.12, 0.068]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "current BMI": "<18.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[4.16, 0.021]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "current BMI": "\u226518.5 but <22.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[37.88, 0.021]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "current BMI": "\u226522.5 but <25"
            },
            "measures": "[percentage, P]",
            "outcomes": "[32.63, 0.021]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "current BMI": "\u226525 but <27.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[16.72, 0.021]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "current BMI": "\u226527.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[7.58, 0.021]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "current BMI": "unknown"
            },
            "measures": "[percentage, P]",
            "outcomes": "[1.02, 0.021]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "BMI at age 20": "<18.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[11.47, 0.018]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "BMI at age 20": "\u226518.5 but <22.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[64.85, 0.018]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "BMI at age 20": "\u226522.5 but <25"
            },
            "measures": "[percentage, P]",
            "outcomes": "[15.43, 0.018]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "BMI at age 20": "\u226525 but <27.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[4.91, 0.018]"
        },
        {
            "subject": {
                "study type": "case-control study",
                "disease": "pancreatic cancer",
                "analysis": "comparison of selected characteristics",
                "group": "controls",
                "BMI at age 20": "\u226527.5"
            },
            "measures": "[percentage, P]",
            "outcomes": "[0.96, 0.018]"
        }
    ],
    "PMC5762325_3": [
        {
            "subject": {
                "analysis": "Correlation analysis",
                "tissue sample": "Tumor tissue sample",
                "E-cadherin expression": "Low",
                "STYK1 expression": "Low",
                "technique": "correlation analysis"
            },
            "measures": "[correlation coefficient, P-value]",
            "outcomes": "[-0.420, <0.001]"
        },
        {
            "subject": {
                "analysis": "Correlation analysis",
                "tissue sample": "Tumor tissue sample",
                "E-cadherin expression": "High",
                "STYK1 expression": "High",
                "technique": "correlation analysis"
            },
            "measures": "[correlation coefficient, P-value]",
            "outcomes": "[, ]"
        }
    ],
    "PMC3798558_3": [
        {
            "subject": {
                "analysis": "haplotype analysis for XRCC1",
                "gene": "XRCC1",
                "haplotype": "1",
                "SNP 1": "rs1799782",
                "SNP 2": "rs25487",
                "statistical method": "haplotype-effects logistic regression",
                "adjustment": "multivariable adjustment by age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, and family history of PC",
                "cases": "185",
                "controls": "1465"
            },
            "measures": "[haplotype frequency overall, adjusted OR, P-value]",
            "outcomes": "[0.439, 1.00 (ref.), ]"
        },
        {
            "subject": {
                "analysis": "haplotype analysis for XRCC1",
                "gene": "XRCC1",
                "haplotype": "2",
                "SNP 1": "rs1799782",
                "SNP 2": "rs25487",
                "statistical method": "haplotype-effects logistic regression",
                "adjustment": "multivariable adjustment by age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, and family history of PC",
                "cases": "185",
                "controls": "1465"
            },
            "measures": "[haplotype frequency overall, adjusted OR, P-value]",
            "outcomes": "[0.240, 1.32 (1.01-1.71), 0.042]"
        },
        {
            "subject": {
                "analysis": "haplotype analysis for XRCC1",
                "gene": "XRCC1",
                "haplotype": "3",
                "SNP 1": "rs1799782",
                "SNP 2": "rs25487",
                "statistical method": "haplotype-effects logistic regression",
                "adjustment": "multivariable adjustment by age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, and family history of PC",
                "cases": "185",
                "controls": "1465"
            },
            "measures": "[haplotype frequency overall, adjusted OR, P-value]",
            "outcomes": "[0.319, 1.05 (0.81-1.36), 0.691]"
        },
        {
            "subject": {
                "analysis": "haplotype analysis for XRCC1",
                "gene": "XRCC1",
                "haplotype": "4",
                "SNP 1": "rs1799782",
                "SNP 2": "rs25487",
                "statistical method": "haplotype-effects logistic regression",
                "adjustment": "multivariable adjustment by age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, and family history of PC",
                "cases": "185",
                "controls": "1465"
            },
            "measures": "[haplotype frequency overall, adjusted OR, P-value]",
            "outcomes": "[0.002, N.E., N.E.]"
        }
    ],
    "PMC4423458_3": [
        {
            "subject": {
                "protein": "Fibrinogen beta chain isoform 1 pre-pro-protein",
                "accession": "70906435",
                "MW (kDa)": "56",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[2.2, 0.01481]"
        },
        {
            "subject": {
                "protein": "C4b-binding protein alpha chain precursor",
                "accession": "4502503",
                "MW (kDa)": "67",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[2.3, 0.04311]"
        },
        {
            "subject": {
                "protein": "Serum albumin pre-pro-protein",
                "accession": "4502027",
                "MW (kDa)": "69",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[2.4, 0.00006]"
        },
        {
            "subject": {
                "protein": "Vitamin D-binding protein isoform 1 precursor",
                "accession": "32483410",
                "MW (kDa)": "53",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[2.4, 0.03919]"
        },
        {
            "subject": {
                "protein": "Kininogen-1 isoform 2 precursor",
                "accession": "4504893",
                "MW (kDa)": "48",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[3.8, 0.01109]"
        },
        {
            "subject": {
                "protein": "Alpha-2-macroglobulin precursor",
                "accession": "66932947",
                "MW (kDa)": "163",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[3.9, 0.00618]"
        },
        {
            "subject": {
                "protein": "Haptoglobin isoform 1 pre-pro-protein",
                "accession": "4826762",
                "MW (kDa)": "45",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[4.2, 0.00024]"
        },
        {
            "subject": {
                "protein": "Fibrinogen gamma chain isoform gamma-B precursor",
                "accession": "70906439",
                "MW (kDa)": "52",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[4.3, 0.00133]"
        },
        {
            "subject": {
                "protein": "Complement C3 precursor",
                "accession": "115298678",
                "MW (kDa)": "187",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[4.3, 0.00612]"
        },
        {
            "subject": {
                "protein": "Myeloperoxidase precursor",
                "accession": "4557759",
                "MW (kDa)": "84",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[5.3, 0.02501]"
        },
        {
            "subject": {
                "protein": "Apolipoprotein A-I pre-pro-protein",
                "accession": "4557321",
                "MW (kDa)": "31",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[5.7, 0.02170]"
        },
        {
            "subject": {
                "protein": "Fibrinogen alpha chain isoform alpha-E pre-pro-protein",
                "accession": "4503689",
                "MW (kDa)": "95",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[6.4, 0.00031]"
        },
        {
            "subject": {
                "protein": "Alpha-2-HS-glycoprotein pre-pro-protein",
                "accession": "156523970",
                "MW (kDa)": "39",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[6.5, 0.00173]"
        },
        {
            "subject": {
                "protein": "Ceruloplasmin precursor",
                "accession": "4557485",
                "MW (kDa)": "122",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[7.5, 0.00114]"
        },
        {
            "subject": {
                "protein": "PREDICTED: complement C4-A isoform 1",
                "accession": "341916194",
                "MW (kDa)": "193",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[7.7, 0.01791]"
        },
        {
            "subject": {
                "protein": "Alpha-1B-glycoprotein precursor",
                "accession": "21071030",
                "MW (kDa)": "54",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[8.3, 0.00468]"
        },
        {
            "subject": {
                "protein": "Inter-alpha-trypsin inhibitor heavy chain H4 isoform 1 precursor",
                "accession": "31542984",
                "MW (kDa)": "103",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[35.4, 0.00484]"
        },
        {
            "subject": {
                "protein": "Apolipoprotein B-100 precursor",
                "accession": "105990532",
                "MW (kDa)": "516",
                "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                "technique": "spectral count",
                "statistical representation": "average SC"
            },
            "measures": "[NSAF ratio, P]",
            "outcomes": "[55.7, 0.02595]"
        }
    ],
    "PMC5589562_2": [
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-145-5p",
                "Accession no.": "MIMAT0000437",
                "Ratio": "8980.05"
            },
            "measures": "[Ratio]",
            "outcomes": "[8980.05]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-199a-5p",
                "Accession no.": "MIMAT0000231",
                "Ratio": "1563.68"
            },
            "measures": "[Ratio]",
            "outcomes": "[1563.68]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-199b-5p",
                "Accession no.": "MIMAT0000263",
                "Ratio": "296.31"
            },
            "measures": "[Ratio]",
            "outcomes": "[296.31]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-136-5p",
                "Accession no.": "MIMAT0000448",
                "Ratio": "228.24"
            },
            "measures": "[Ratio]",
            "outcomes": "[228.24]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-137",
                "Accession no.": "MIMAT0000429",
                "Ratio": "227.70"
            },
            "measures": "[Ratio]",
            "outcomes": "[227.70]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-139-5p",
                "Accession no.": "MIMAT0000250",
                "Ratio": "216.83"
            },
            "measures": "[Ratio]",
            "outcomes": "[216.83]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-127-3p",
                "Accession no.": "MIMAT0000446",
                "Ratio": "159.72"
            },
            "measures": "[Ratio]",
            "outcomes": "[159.72]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-337-5p",
                "Accession no.": "MIMAT0004695",
                "Ratio": "148.57"
            },
            "measures": "[Ratio]",
            "outcomes": "[148.57]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-139-3p",
                "Accession no.": "MIMAT0004552",
                "Ratio": "146.36"
            },
            "measures": "[Ratio]",
            "outcomes": "[146.36]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-487b",
                "Accession no.": "MIMAT0003180",
                "Ratio": "118.72"
            },
            "measures": "[Ratio]",
            "outcomes": "[118.72]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                "Accession no.": "MIMAT0000232",
                "Ratio": "107.49"
            },
            "measures": "[Ratio]",
            "outcomes": "[107.49]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-1233",
                "Accession no.": "MIMAT0005588",
                "Ratio": "66.04"
            },
            "measures": "[Ratio]",
            "outcomes": "[66.04]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-379-5p",
                "Accession no.": "MIMAT0000733",
                "Ratio": "62.89"
            },
            "measures": "[Ratio]",
            "outcomes": "[62.89]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-660-5p",
                "Accession no.": "MIMAT0003338",
                "Ratio": "62.50"
            },
            "measures": "[Ratio]",
            "outcomes": "[62.50]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "TAS cells",
                "miRNA probe ID": "hsa-miR-335-5p",
                "Accession no.": "MIMAT0000765",
                "Ratio": "60.53"
            },
            "measures": "[Ratio]",
            "outcomes": "[60.53]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-205-5p",
                "Accession no.": "MIMAT0000266",
                "Ratio": "23077.19"
            },
            "measures": "[Ratio]",
            "outcomes": "[23077.19]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-200c-3p",
                "Accession no.": "MIMAT0000617",
                "Ratio": "5968.64"
            },
            "measures": "[Ratio]",
            "outcomes": "[5968.64]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-200b-3p",
                "Accession no.": "MIMAT0000318",
                "Ratio": "467.15"
            },
            "measures": "[Ratio]",
            "outcomes": "[467.15]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-429",
                "Accession no.": "MIMAT0001536",
                "Ratio": "171.07"
            },
            "measures": "[Ratio]",
            "outcomes": "[171.07]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-196b-5p",
                "Accession no.": "MIMAT0001080",
                "Ratio": "116.42"
            },
            "measures": "[Ratio]",
            "outcomes": "[116.42]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-582-5p",
                "Accession no.": "MIMAT0003247",
                "Ratio": "99.53"
            },
            "measures": "[Ratio]",
            "outcomes": "[99.53]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-135b-5p",
                "Accession no.": "MIMAT0000758",
                "Ratio": "87.82"
            },
            "measures": "[Ratio]",
            "outcomes": "[87.82]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-182-5p",
                "Accession no.": "MIMAT0000259",
                "Ratio": "55.81"
            },
            "measures": "[Ratio]",
            "outcomes": "[55.81]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-96-5p",
                "Accession no.": "MIMAT0000095",
                "Ratio": "53.82"
            },
            "measures": "[Ratio]",
            "outcomes": "[53.82]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-200a-3p",
                "Accession no.": "MIMAT0000682",
                "Ratio": "44.88"
            },
            "measures": "[Ratio]",
            "outcomes": "[44.88]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-4284",
                "Accession no.": "MIMAT0016915",
                "Ratio": "41.90"
            },
            "measures": "[Ratio]",
            "outcomes": "[41.90]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-345-5p",
                "Accession no.": "MIMAT0000772",
                "Ratio": "27.99"
            },
            "measures": "[Ratio]",
            "outcomes": "[27.99]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-378g",
                "Accession no.": "MIMAT0018937",
                "Ratio": "25.01"
            },
            "measures": "[Ratio]",
            "outcomes": "[25.01]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-203",
                "Accession no.": "MIMAT0000264",
                "Ratio": "22.43"
            },
            "measures": "[Ratio]",
            "outcomes": "[22.43]"
        },
        {
            "subject": {
                "study": "this study",
                "analysis": "miRNA expression analysis",
                "cell type": "PC cells",
                "miRNA probe ID": "hsa-miR-141-3p",
                "Accession no.": "MIMAT0000432",
                "Ratio": "21.69"
            },
            "measures": "[Ratio]",
            "outcomes": "[21.69]"
        }
    ],
    "PMC4190529_6": [
        {
            "subject": {
                "treatment": "gemcitabine",
                "control": "5-fluorouracil",
                "phase": "3",
                "study type": "pancreatic cancer treatment",
                "FDA approval": "1996"
            },
            "measures": "[median survival therapy, median survival control, one-year survival therapy, one-year survival control]",
            "outcomes": "[5.7, 4.2, 18%, 2%]"
        },
        {
            "subject": {
                "treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                "control": "gemcitabine",
                "phase": "3",
                "study type": "pancreatic cancer treatment",
                "FDA approval": "2005"
            },
            "measures": "[median survival therapy, median survival control, one-year survival therapy, one-year survival control]",
            "outcomes": "[6.4, 6, 24%, 19%]"
        },
        {
            "subject": {
                "treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                "control": "gemcitabine",
                "phase": "3",
                "study type": "pancreatic cancer treatment",
                "FDA approval": "2013"
            },
            "measures": "[median survival therapy, median survival control, one-year survival therapy, one-year survival control]",
            "outcomes": "[8.5, 6.7, 35%, 22%]"
        },
        {
            "subject": {
                "treatment": "FOLFIRINOX",
                "control": "gemcitabine",
                "phase": "2/3",
                "study type": "pancreatic cancer treatment",
                "FDA approval": "n/a"
            },
            "measures": "[median survival therapy, median survival control, one-year survival therapy, one-year survival control]",
            "outcomes": "[11.1, 6.8, 48.4%, 20.6%]"
        },
        {
            "subject": {
                "treatment": "cell encapsulation + ifosfamide",
                "control": "5-fluorouracil",
                "phase": "2",
                "study type": "pancreatic cancer treatment",
                "FDA approval": "n/a"
            },
            "measures": "[median survival therapy, median survival control, one-year survival therapy, one-year survival control]",
            "outcomes": "[10, 5, 36%, 18%]"
        }
    ],
    "PMC5675623_3": [
        {
            "subject": {
                "analysis": "multivariate Cox proportional hazards regression analysis",
                "dependent variable": "overall survival (OS)",
                "independent variable": "ECOG performance status",
                "contrast": "> 0 vs. 0",
                "statistical model": "Cox proportional hazards regression",
                "treatment": "first phase I treatment"
            },
            "measures": "[hazard ratio, P value]",
            "outcomes": "[1.47 (0.90, 2.41), 0.12]"
        },
        {
            "subject": {
                "analysis": "multivariate Cox proportional hazards regression analysis",
                "dependent variable": "overall survival (OS)",
                "independent variable": "Liver metastases",
                "contrast": "Yes vs. No",
                "statistical model": "Cox proportional hazards regression",
                "treatment": "first phase I treatment"
            },
            "measures": "[hazard ratio, P value]",
            "outcomes": "[1.72 (1.01, 2.91), 0.045]"
        },
        {
            "subject": {
                "analysis": "multivariate Cox proportional hazards regression analysis",
                "dependent variable": "overall survival (OS)",
                "independent variable": "No. of metastatic sites",
                "contrast": ">2 vs. <= 2",
                "statistical model": "Cox proportional hazards regression",
                "treatment": "first phase I treatment"
            },
            "measures": "[hazard ratio, P value]",
            "outcomes": "[1.33 (0.9, 2.25), 0.28]"
        },
        {
            "subject": {
                "analysis": "multivariate Cox proportional hazards regression analysis",
                "dependent variable": "overall survival (OS)",
                "independent variable": "Prior radiation therapy",
                "contrast": "Yes vs. No",
                "statistical model": "Cox proportional hazards regression",
                "treatment": "first phase I treatment"
            },
            "measures": "[hazard ratio, P value]",
            "outcomes": "[1.58 (0.95, 2.61), 0.077]"
        },
        {
            "subject": {
                "analysis": "multivariate Cox proportional hazards regression analysis",
                "dependent variable": "overall survival (OS)",
                "independent variable": "Prior FOLFIRINOX",
                "contrast": "Yes vs. No",
                "statistical model": "Cox proportional hazards regression",
                "treatment": "first phase I treatment"
            },
            "measures": "[hazard ratio, P value]",
            "outcomes": "[1.73 (1.01, 2.98), 0.046]"
        },
        {
            "subject": {
                "analysis": "multivariate Cox proportional hazards regression analysis",
                "dependent variable": "overall survival (OS)",
                "independent variable": "Prior gemcitabine plus nab-paclitaxel treatment",
                "contrast": "Yes vs. No",
                "statistical model": "Cox proportional hazards regression",
                "treatment": "first phase I treatment"
            },
            "measures": "[hazard ratio, P value]",
            "outcomes": "[1.08 (0.58, 2.01), 0.80]"
        }
    ],
    "PMC4742219_3": [
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Age",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[hazard ratio, P]",
            "outcomes": "[1.00 (0.98, 1.02), 0.874]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Gender (female vs. male)",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[hazard ratio, P]",
            "outcomes": "[0.89 (0.60, 1.31), 0.544]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Tumor size",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[hazard ratio, P]",
            "outcomes": "[1.13 (0.97, 1.33), 0.127]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Tumor grade",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Grade II vs. I",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[hazard ratio, P]",
            "outcomes": "[1.00 (0.69, 1.45), 0.991]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Grade III vs. I",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[hazard ratio, P]",
            "outcomes": "[0.93 (0.27, 3.17), 0.906]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Lymph Nodes (yes vs. no)",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[hazard ratio, P]",
            "outcomes": "[1.39 (0.81, 2.38), 0.229]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Margin (positive vs. negative)",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[hazard ratio, P]",
            "outcomes": "[1.54 (1.06, 2.25), 0.025]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Vascular invasion (yes vs. no)",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[hazard ratio, P]",
            "outcomes": "[0.99 (0.69, 1.42), 0.967]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Perineural invasion (yes vs. no)",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[hazard ratio, P]",
            "outcomes": "[2.19 (0.87, 5.49), 0.097]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Time from surgery to first recurrence",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[hazard ratio, P]",
            "outcomes": "[1.00 (0.98, 1.02), 0.883]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Recurrence pattern",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Lung + Other vs. Lung",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[hazard ratio, P]",
            "outcomes": "[1.25 (0.63, 2.48), 0.516]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Liver + Other vs. Lung",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[hazard ratio, P]",
            "outcomes": "[1.91 (1.10, 3.31), 0.022]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Peritoneal vs. Lung",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[hazard ratio, P]",
            "outcomes": "[6.32 (3.12, 12.79), < 0.001]"
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Local vs. Lung",
                "statistical representation": "HR (95% CI)",
                "footnote": "HR = hazard ratio; CI = confidence interval"
            },
            "measures": "[hazard ratio, P]",
            "outcomes": "[2.09 (1.10, 4.00), 0.025]"
        }
    ],
    "PMC4941379_3": [
        {
            "subject": {
                "analysis": "Risk of gastric cancer incidence",
                "chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG-/CagA-",
                "sample size": "4555",
                "cases": "5",
                "crude incidence rate": "10.42 per 100,000 person-years",
                "HR type": "HR1"
            },
            "measures": "[crude incidence rate, HR]",
            "outcomes": "[10.42, Ref]"
        },
        {
            "subject": {
                "analysis": "Risk of gastric cancer incidence",
                "chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG+/CagA-",
                "sample size": "1984",
                "cases": "2",
                "crude incidence rate": "9.54 per 100,000 person-years",
                "HR type": "HR1"
            },
            "measures": "[crude incidence rate, HR]",
            "outcomes": "[9.54, 0.79 (0.15\u20134.08)]"
        },
        {
            "subject": {
                "analysis": "Risk of gastric cancer incidence",
                "chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG+/CagA+",
                "sample size": "2295",
                "cases": "14",
                "crude incidence rate": "58.13 per 100,000 person-years",
                "HR type": "HR1"
            },
            "measures": "[crude incidence rate, HR]",
            "outcomes": "[58.13, 5.05 (1.81\u201314.09)]"
        },
        {
            "subject": {
                "analysis": "Risk of gastric cancer incidence",
                "chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG-/CagA-",
                "sample size": "205",
                "cases": "0",
                "crude incidence rate": "0 per 100,000 person-years",
                "HR type": "HR1"
            },
            "measures": "[crude incidence rate, HR]",
            "outcomes": "[0, 3.45 (1.38\u20138.64)]"
        },
        {
            "subject": {
                "analysis": "Risk of gastric cancer incidence",
                "chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG+/CagA-",
                "sample size": "143",
                "cases": "1",
                "crude incidence rate": "64.61 per 100,000 person-years",
                "HR type": "HR1"
            },
            "measures": "[crude incidence rate, HR]",
            "outcomes": "[64.61, 5.50 (0.63\u201347.57)]"
        },
        {
            "subject": {
                "analysis": "Risk of gastric cancer incidence",
                "chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG+/CagA+",
                "sample size": "315",
                "cases": "5",
                "crude incidence rate": "151.20 per 100,000 person-years",
                "HR type": "HR1"
            },
            "measures": "[crude incidence rate, HR]",
            "outcomes": "[151.20, 12.51 (3.57\u201343.22)]"
        },
        {
            "subject": {
                "analysis": "Risk of gastric cancer incidence",
                "chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG-/CagA-",
                "sample size": "4555",
                "cases": "5",
                "crude incidence rate": "10.42 per 100,000 person-years",
                "HR type": "HR2"
            },
            "measures": "[crude incidence rate, HR]",
            "outcomes": "[10.42, Ref]"
        },
        {
            "subject": {
                "analysis": "Risk of gastric cancer incidence",
                "chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG+/CagA-",
                "sample size": "1984",
                "cases": "2",
                "crude incidence rate": "9.54 per 100,000 person-years",
                "HR type": "HR2"
            },
            "measures": "[crude incidence rate, HR]",
            "outcomes": "[9.54, 0.79 (0.15\u20134.08)]"
        },
        {
            "subject": {
                "analysis": "Risk of gastric cancer incidence",
                "chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG+/CagA+",
                "sample size": "2295",
                "cases": "14",
                "crude incidence rate": "58.13 per 100,000 person-years",
                "HR type": "HR2"
            },
            "measures": "[crude incidence rate, HR]",
            "outcomes": "[58.13, 5.05 (1.81\u201314.09)]"
        },
        {
            "subject": {
                "analysis": "Risk of gastric cancer incidence",
                "chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG-/CagA-",
                "sample size": "205",
                "cases": "0",
                "crude incidence rate": "0 per 100,000 person-years",
                "HR type": "HR2"
            },
            "measures": "[crude incidence rate, HR]",
            "outcomes": "[0, Not estimable]"
        },
        {
            "subject": {
                "analysis": "Risk of gastric cancer incidence",
                "chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG+/CagA-",
                "sample size": "143",
                "cases": "1",
                "crude incidence rate": "64.61 per 100,000 person-years",
                "HR type": "HR2"
            },
            "measures": "[crude incidence rate, HR]",
            "outcomes": "[64.61, 5.50 (0.63\u201347.57)]"
        },
        {
            "subject": {
                "analysis": "Risk of gastric cancer incidence",
                "chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG+/CagA+",
                "sample size": "315",
                "cases": "5",
                "crude incidence rate": "151.20 per 100,000 person-years",
                "HR type": "HR2"
            },
            "measures": "[crude incidence rate, HR]",
            "outcomes": "[151.20, 12.51 (3.57\u201343.22)]"
        }
    ],
    "PMC3987090_4": [
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "univariate analysis",
                "NLR threshold": "\u22641",
                "n": "14",
                "percentage": "5.6",
                "median OS": "12.8 months",
                "95% CI": "0.86\u20133.29",
                "hazard ratio": "1",
                "P-value": "0.13"
            },
            "measures": "[median OS, hazard ratio, P-value]",
            "outcomes": "[12.8 months, 1, 0.13]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "univariate analysis",
                "NLR threshold": ">1",
                "n": "238",
                "percentage": "94.4",
                "median OS": "11.7 months",
                "95% CI": "",
                "hazard ratio": "1.68",
                "P-value": "0.13"
            },
            "measures": "[median OS, hazard ratio, P-value]",
            "outcomes": "[11.7 months, 1.68, 0.13]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "multivariate analysis",
                "NLR threshold": "\u22641",
                "n": "14",
                "percentage": "5.6",
                "hazard ratio": "1",
                "95% CI": "0.69\u20132.71",
                "P-value": "0.37"
            },
            "measures": "[hazard ratio, P-value]",
            "outcomes": "[1, 0.37]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "multivariate analysis",
                "NLR threshold": ">1",
                "n": "238",
                "percentage": "94.4",
                "hazard ratio": "1.37",
                "95% CI": "",
                "P-value": "0.37"
            },
            "measures": "[hazard ratio, P-value]",
            "outcomes": "[1.37, 0.37]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "univariate analysis",
                "NLR threshold": "\u22642",
                "n": "83",
                "percentage": "32.9",
                "median OS": "14.8 months",
                "95% CI": "1.13\u20132.05",
                "hazard ratio": "1",
                "P-value": "0.01"
            },
            "measures": "[median OS, hazard ratio, P-value]",
            "outcomes": "[14.8 months, 1, 0.01]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "univariate analysis",
                "NLR threshold": ">2",
                "n": "169",
                "percentage": "67.1",
                "median OS": "10.7 months",
                "95% CI": "",
                "hazard ratio": "1.52",
                "P-value": "0.01"
            },
            "measures": "[median OS, hazard ratio, P-value]",
            "outcomes": "[10.7 months, 1.52, 0.01]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "multivariate analysis",
                "NLR threshold": "\u22642",
                "n": "83",
                "percentage": "32.9",
                "hazard ratio": "1",
                "95% CI": "0.88\u20131.66",
                "P-value": "0.24"
            },
            "measures": "[hazard ratio, P-value]",
            "outcomes": "[1, 0.24]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "multivariate analysis",
                "NLR threshold": ">2",
                "n": "169",
                "percentage": "67.1",
                "hazard ratio": "1.21",
                "95% CI": "",
                "P-value": "0.24"
            },
            "measures": "[hazard ratio, P-value]",
            "outcomes": "[1.21, 0.24]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "univariate analysis",
                "NLR threshold": "\u22643",
                "n": "158",
                "percentage": "62.7",
                "median OS": "13.4 months",
                "95% CI": "1.26\u20132.23",
                "hazard ratio": "1",
                "P-value": "<0.01"
            },
            "measures": "[median OS, hazard ratio, P-value]",
            "outcomes": "[13.4 months, 1, <0.01]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "univariate analysis",
                "NLR threshold": ">3",
                "n": "94",
                "percentage": "37.3",
                "median OS": "8.6 months",
                "95% CI": "",
                "hazard ratio": "1.68",
                "P-value": "<0.01"
            },
            "measures": "[median OS, hazard ratio, P-value]",
            "outcomes": "[8.6 months, 1.68, <0.01]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "multivariate analysis",
                "NLR threshold": "\u22643",
                "n": "158",
                "percentage": "62.7",
                "hazard ratio": "1",
                "95% CI": "1.18\u20132.11",
                "P-value": "<0.01"
            },
            "measures": "[hazard ratio, P-value]",
            "outcomes": "[1, <0.01]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "multivariate analysis",
                "NLR threshold": ">3",
                "n": "94",
                "percentage": "37.3",
                "hazard ratio": "1.57",
                "95% CI": "",
                "P-value": "<0.01"
            },
            "measures": "[hazard ratio, P-value]",
            "outcomes": "[1.57, <0.01]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "univariate analysis",
                "NLR threshold": "\u22644",
                "n": "194",
                "percentage": "77.0",
                "median OS": "13.3 months",
                "95% CI": "1.44\u20132.78",
                "hazard ratio": "1",
                "P-value": "<0.01"
            },
            "measures": "[median OS, hazard ratio, P-value]",
            "outcomes": "[13.3 months, 1, <0.01]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "univariate analysis",
                "NLR threshold": ">4",
                "n": "58",
                "percentage": "23.0",
                "median OS": "7.3 months",
                "95% CI": "",
                "hazard ratio": "2.00",
                "P-value": "<0.01"
            },
            "measures": "[median OS, hazard ratio, P-value]",
            "outcomes": "[7.3 months, 2.00, <0.01]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "multivariate analysis",
                "NLR threshold": "\u22644",
                "n": "194",
                "percentage": "77.0",
                "hazard ratio": "1",
                "95% CI": "1.36\u20132.67",
                "P-value": "<0.01"
            },
            "measures": "[hazard ratio, P-value]",
            "outcomes": "[1, <0.01]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "multivariate analysis",
                "NLR threshold": ">4",
                "n": "58",
                "percentage": "23.0",
                "hazard ratio": "1.91",
                "95% CI": "",
                "P-value": "<0.01"
            },
            "measures": "[hazard ratio, P-value]",
            "outcomes": "[1.91, <0.01]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "univariate analysis",
                "NLR threshold": "\u22645",
                "n": "212",
                "percentage": "84.1",
                "median OS": "12.8 months",
                "95% CI": "1.50\u20133.15",
                "hazard ratio": "1",
                "P-value": "<0.01"
            },
            "measures": "[median OS, hazard ratio, P-value]",
            "outcomes": "[12.8 months, 1, <0.01]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "univariate analysis",
                "NLR threshold": ">5",
                "n": "40",
                "percentage": "15.9",
                "median OS": "6.0 months",
                "95% CI": "",
                "hazard ratio": "2.17",
                "P-value": "<0.01"
            },
            "measures": "[median OS, hazard ratio, P-value]",
            "outcomes": "[6.0 months, 2.17, <0.01]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "multivariate analysis",
                "NLR threshold": "\u22645",
                "n": "212",
                "percentage": "84.1",
                "hazard ratio": "1",
                "95% CI": "1.49\u20133.15",
                "P-value": "<0.01"
            },
            "measures": "[hazard ratio, P-value]",
            "outcomes": "[1, <0.01]"
        },
        {
            "subject": {
                "analysis": "The NLR thresholds and relationship with survival",
                "type": "multivariate analysis",
                "NLR threshold": ">5",
                "n": "40",
                "percentage": "15.9",
                "hazard ratio": "2.16",
                "95% CI": "",
                "P-value": "<0.01"
            },
            "measures": "[hazard ratio, P-value]",
            "outcomes": "[2.16, <0.01]"
        }
    ],
    "PMC3987090_5": [
        {
            "subject": {
                "study": "An X et al.",
                "year": "2010",
                "n": "89",
                "prognostic factor": "NLR",
                "patient group": "APC patients receiving chemotherapy",
                "association": "NLR and prognosis"
            },
            "measures": "[overall survival (NLR >5 vs. \u22645), hazard ratio]",
            "outcomes": "[2.4 vs. 7.7, 4.49]"
        },
        {
            "subject": {
                "study": "Wang DS et al.",
                "year": "2012",
                "n": "86",
                "prognostic factor": "NLR",
                "patient group": "APC patients receiving chemotherapy",
                "association": "NLR and prognosis"
            },
            "measures": "[overall survival (NLR >5 vs. \u22645)]",
            "outcomes": "[5.8 vs. 10.2]"
        },
        {
            "subject": {
                "study": "Stotz M et al",
                "year": "2013",
                "n": "261",
                "prognostic factor": "NLR",
                "patient group": "APC patients receiving chemotherapy",
                "association": "NLR and prognosis"
            },
            "measures": "[hazard ratio]",
            "outcomes": "[2.53]"
        },
        {
            "subject": {
                "study": "Our study",
                "year": "2013",
                "n": "253",
                "prognostic factor": "NLR",
                "patient group": "APC patients receiving chemotherapy",
                "association": "NLR and prognosis"
            },
            "measures": "[overall survival (NLR >5 vs. \u22645), hazard ratio]",
            "outcomes": "[6.0 vs. 12.8, 1.95]"
        }
    ],
    "PMC3544459_4": [
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Diabetes",
                "status": "No",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "33.2",
                "P value (log-rank)": "0.049"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, 0.050]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Diabetes",
                "status": "Yes",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "24.6",
                "P value (log-rank)": "0.049"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.27 (1.00\u20131.60), 0.050]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Diabetes",
                "status": "No",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "33.2",
                "P value (log-rank)": "0.049"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, 0.036]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Diabetes",
                "status": "Yes",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "24.6",
                "P value (log-rank)": "0.049"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.29 (1.02\u20131.64), 0.036]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Perineural invasion",
                "status": "No",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "51.7",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, <0.001]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Perineural invasion",
                "status": "Yes",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "29.4",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[2.01 (1.38\u20132.93), <0.001]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Perineural invasion",
                "status": "No",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "51.7",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, 0.019]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Perineural invasion",
                "status": "Yes",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "29.4",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.60 (1.08\u20132.36), 0.019]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Margin status",
                "status": "Negative",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "33.6",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, <0.001]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Margin status",
                "status": "Positive",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "24.8",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.62 (1.27\u20132.08), <0.001]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Margin status",
                "status": "Negative",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "33.6",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, 0.003]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Margin status",
                "status": "Positive",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "24.8",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.47 (1.14\u20131.90), 0.003]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Node status",
                "status": "Negative",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "38.6",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, <0.001]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Node status",
                "status": "Positive",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "27.5",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.70 (1.35\u20132.15), <0.001]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Node status",
                "status": "Negative",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "38.6",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, 0.002]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Node status",
                "status": "Positive",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "27.5",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.45 (1.14\u20131.83), 0.002]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Differentiation",
                "status": "Well\u2013moderate",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "35.9",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, <0.001]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Differentiation",
                "status": "Poor",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "26.0",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.63 (1.32\u20132.02), <0.001]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Differentiation",
                "status": "Well\u2013moderate",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "35.9",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, <0.001]"
        },
        {
            "subject": {
                "analysis": "Overall survival and risk of death by clinical characteristics",
                "condition": "Differentiation",
                "status": "Poor",
                "statistical representation": "mean +- SD",
                "median survival time (months)": "26.0",
                "P value (log-rank)": "<0.001"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.63 (1.32\u20132.02), <0.001]"
        }
    ],
    "PMC3497287_3": [
        {
            "subject": {
                "syndrome": "Lynch Syndrome",
                "mutated gene": "Mismatch Repair Genes (MMR): MLH1, MSH2, MSH6 and PMS2",
                "category": "Inherited pancreatic cancer syndromes"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "syndrome": "Peutz-Jeghers Syndrome",
                "mutated gene": "STK11/LKB1",
                "category": "Inherited pancreatic cancer syndromes"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "syndrome": "Hereditary Breast Cancer",
                "mutated gene": "BRCA1/BRCA2",
                "category": "Inherited pancreatic cancer syndromes"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "syndrome": "Familial Atypical Multiple Mole Melanoma",
                "mutated gene": "CDKN2A mutation",
                "category": "Inherited pancreatic cancer syndromes"
            },
            "measures": "[]",
            "outcomes": "[]"
        }
    ],
    "PMC4728116_3": [
        {
            "subject": {
                "characteristic": "Family history of pancreatic cancer",
                "group": "Cases",
                "n": "312",
                "percentage": "-96.6",
                "reference": "Yes",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.00 (reference), 1.00 (reference)]"
        },
        {
            "subject": {
                "characteristic": "Family history of pancreatic cancer",
                "group": "Controls",
                "n": "320",
                "percentage": "-99.1",
                "reference": "Yes",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.00 (reference), 1.00 (reference)]"
        },
        {
            "subject": {
                "characteristic": "Family history of pancreatic cancer",
                "group": "Cases",
                "n": "11",
                "percentage": "-3.4",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[3.67 (1.02\u201313.14), 1.02\u201313.14]"
        },
        {
            "subject": {
                "characteristic": "Family history of pancreatic cancer",
                "group": "Controls",
                "n": "3",
                "percentage": "-0.9",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[3.67 (1.02\u201313.14), 1.02\u201313.14]"
        },
        {
            "subject": {
                "characteristic": "Family history of pancreatic cancer",
                "group": "Cases",
                "n": "11",
                "percentage": "-3.4",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR1 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[4.04 (1.08\u201315.07), 1.08\u201315.07]"
        },
        {
            "subject": {
                "characteristic": "Family history of pancreatic cancer",
                "group": "Controls",
                "n": "3",
                "percentage": "-0.9",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR1 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[4.04 (1.08\u201315.07), 1.08\u201315.07]"
        },
        {
            "subject": {
                "characteristic": "Family history of pancreatic cancer",
                "group": "Cases",
                "n": "11",
                "percentage": "-3.4",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR2 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.23 (1.11\u20133.70), 1.11\u20133.70]"
        },
        {
            "subject": {
                "characteristic": "Family history of pancreatic cancer",
                "group": "Controls",
                "n": "3",
                "percentage": "-0.9",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR2 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.23 (1.11\u20133.70), 1.11\u20133.70]"
        },
        {
            "subject": {
                "characteristic": "BMI",
                "group": "Cases",
                "n": "197",
                "percentage": "-61.0",
                "reference": "Yes",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.00 (reference), 1.00 (reference)]"
        },
        {
            "subject": {
                "characteristic": "BMI",
                "group": "Controls",
                "n": "230",
                "percentage": "-71.2",
                "reference": "Yes",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.00 (reference), 1.00 (reference)]"
        },
        {
            "subject": {
                "characteristic": "BMI",
                "group": "Cases",
                "n": "126",
                "percentage": "-39.0",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.67 (1.18\u20132.38), 1.18\u20132.38]"
        },
        {
            "subject": {
                "characteristic": "BMI",
                "group": "Controls",
                "n": "93",
                "percentage": "-28.8",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.67 (1.18\u20132.38), 1.18\u20132.38]"
        },
        {
            "subject": {
                "characteristic": "BMI",
                "group": "Cases",
                "n": "126",
                "percentage": "-39.0",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR1 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.78 (1.23\u20132.58), 1.23\u20132.58]"
        },
        {
            "subject": {
                "characteristic": "BMI",
                "group": "Controls",
                "n": "93",
                "percentage": "-28.8",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR1 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.78 (1.23\u20132.58), 1.23\u20132.58]"
        },
        {
            "subject": {
                "characteristic": "BMI",
                "group": "Cases",
                "n": "126",
                "percentage": "-39.0",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR2 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.77 (1.22\u20132.57), 1.22\u20132.57]"
        },
        {
            "subject": {
                "characteristic": "BMI",
                "group": "Controls",
                "n": "93",
                "percentage": "-28.8",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR2 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.77 (1.22\u20132.57), 1.22\u20132.57]"
        },
        {
            "subject": {
                "characteristic": "Diabetes",
                "group": "Cases",
                "n": "174",
                "percentage": "-78.0",
                "reference": "Yes",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.00 (reference), 1.00 (reference)]"
        },
        {
            "subject": {
                "characteristic": "Diabetes",
                "group": "Controls",
                "n": "255",
                "percentage": "-90.7",
                "reference": "Yes",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.00 (reference), 1.00 (reference)]"
        },
        {
            "subject": {
                "characteristic": "Diabetes",
                "group": "Cases",
                "n": "49",
                "percentage": "-22.0",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[2.69 (1.51\u20134.77), 1.51\u20134.77]"
        },
        {
            "subject": {
                "characteristic": "Diabetes",
                "group": "Controls",
                "n": "26",
                "percentage": "-9.3",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[2.69 (1.51\u20134.77), 1.51\u20134.77]"
        },
        {
            "subject": {
                "characteristic": "Diabetes",
                "group": "Cases",
                "n": "49",
                "percentage": "-22.0",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR1 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[2.60 (1.41\u20134.79), 1.41\u20134.79]"
        },
        {
            "subject": {
                "characteristic": "Diabetes",
                "group": "Controls",
                "n": "26",
                "percentage": "-9.3",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR1 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[2.60 (1.41\u20134.79), 1.41\u20134.79]"
        },
        {
            "subject": {
                "characteristic": "Diabetes",
                "group": "Cases",
                "n": "49",
                "percentage": "-22.0",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR2 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[2.96 (1.48\u20135.92), 1.48\u20135.92]"
        },
        {
            "subject": {
                "characteristic": "Diabetes",
                "group": "Controls",
                "n": "26",
                "percentage": "-9.3",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR2 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[2.96 (1.48\u20135.92), 1.48\u20135.92]"
        },
        {
            "subject": {
                "characteristic": "Cholecystitis",
                "group": "Cases",
                "n": "272",
                "percentage": "-94.1",
                "reference": "Yes",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.00 (reference), 1.00 (reference)]"
        },
        {
            "subject": {
                "characteristic": "Cholecystitis",
                "group": "Controls",
                "n": "195",
                "percentage": "-96.7",
                "reference": "Yes",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.00 (reference), 1.00 (reference)]"
        },
        {
            "subject": {
                "characteristic": "Cholecystitis",
                "group": "Cases",
                "n": "17",
                "percentage": "-5.9",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.89 (0.84\u20134.24), 0.84\u20134.24]"
        },
        {
            "subject": {
                "characteristic": "Cholecystitis",
                "group": "Controls",
                "n": "10",
                "percentage": "-3.3",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.89 (0.84\u20134.24), 0.84\u20134.24]"
        },
        {
            "subject": {
                "characteristic": "Cholecystitis",
                "group": "Cases",
                "n": "17",
                "percentage": "-5.9",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR1 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.91 (0.83\u20134.38), 0.83\u20134.38]"
        },
        {
            "subject": {
                "characteristic": "Cholecystitis",
                "group": "Controls",
                "n": "10",
                "percentage": "-3.3",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR1 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.91 (0.83\u20134.38), 0.83\u20134.38]"
        },
        {
            "subject": {
                "characteristic": "Cholecystitis",
                "group": "Cases",
                "n": "17",
                "percentage": "-5.9",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR2 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.35 (0.50\u20133.68), 0.50\u20133.68]"
        },
        {
            "subject": {
                "characteristic": "Cholecystitis",
                "group": "Controls",
                "n": "10",
                "percentage": "-3.3",
                "reference": "No",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Adjusted OR2 (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.35 (0.50\u20133.68), 0.50\u20133.68]"
        },
        {
            "subject": {
                "characteristic": "Gallstone",
                "group": "Cases",
                "n": "274",
                "percentage": "-95.1",
                "reference": "Yes",
                "analysis": "Characteristics of patients associated with risk of pancreatic cancer",
                "statistical representation": "Crude OR (95% CI)"
            },
            "measures": "[OR, CI]",
            "outcomes": "[1.00 (reference), 1.00 (reference)]"
        }
    ],
    "PMC4741511_2": [
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "study population",
                "stratification": "LDH serum levels and treatment",
                "treatment": "chemotherapy plus sorafenib",
                "LDH serum levels": "\u2264 UNR",
                "patients number": "31",
                "patients percentage": "44%"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[7.6, 12.7]"
        },
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "study population",
                "stratification": "LDH serum levels and treatment",
                "treatment": "chemotherapy plus sorafenib",
                "LDH serum levels": "> UNR",
                "patients number": "6",
                "patients percentage": "8%"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[2.8, 5.9]"
        },
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "study population",
                "stratification": "LDH serum levels and treatment",
                "treatment": "chemotherapy alone",
                "LDH serum levels": "\u2264 UNR",
                "patients number": "27",
                "patients percentage": "38%"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[3.3, 8.6]"
        },
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "study population",
                "stratification": "LDH serum levels and treatment",
                "treatment": "chemotherapy alone",
                "LDH serum levels": "> UNR",
                "patients number": "7",
                "patients percentage": "10%"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[2.2, 5.2]"
        },
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "study population",
                "stratification": "LDH serum levels and treatment",
                "statistical test": "p",
                "PFS": "0.05",
                "OS": "0.0012"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[0.05, 0.0012]"
        }
    ],
    "PMC5522086_3": [
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "TP53",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-2.353"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-2.353, 3.34\u00d710^\u221232]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "NUPR1",
                "log ratio": "-2.52",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-3.977"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-3.977, 4.62\u00d710^\u221213]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "NKX2-3",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-3.455"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-3.455, 5.88\u00d710^\u221212]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "HNF1A",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-2.359"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-2.359, 8.82\u00d710^\u221212]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "CDKN2A",
                "log ratio": "1.737",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-3.219"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-3.219, 1.34\u00d710^\u221211]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "estrogen receptor",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-2.299"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-2.299, 9.57\u00d710^\u221210]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "RB1",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-4.286"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-4.286, 3.74\u00d710^\u221208]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "TCF3",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-3.116"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-3.116, 4.32\u00d710^\u221208]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "TRIM24",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-3.714"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-3.714, 6.26\u00d710^\u221207]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "BCL6",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-2.313"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-2.313, 1.60\u00d710^\u221206]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "NR5A2",
                "log ratio": "-2.876",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-2.7"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-2.7, 7.26\u00d710^\u221206]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "SATB1",
                "log ratio": "-0.814",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-2.003"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-2.003, 1.09\u00d710^\u221205]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "IRF4",
                "log ratio": "2.115",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-2.41"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-2.41, 4.24\u00d710^\u221205]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "RBL1",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-3.124"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-3.124, 1.72\u00d710^\u221204]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "SPDEF",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": "-2.887"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[-2.887, 2.39\u00d710^\u221204]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "Inhibition",
                "activation type": "inhibition",
                "statistical parameter": "Activation z-score",
                "statistical representation": ""
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[, ]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "STAT3",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "2.924"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[2.924, 5.78\u00d710^\u221219]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "CTNNB1",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "3.359"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[3.359, 1.99\u00d710^\u221215]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "SP1",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "2.06"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[2.06, 4.79\u00d710^\u221213]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "CEBPB",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "2.866"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[2.866, 2.62\u00d710^\u221212]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "NFkB (complex)",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "6.314"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[6.314, 1.43\u00d710^\u221211]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "TBX2",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "4.99"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[4.99, 1.62\u00d710^\u221211]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "IRF1",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "3.759"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[3.759, 2.76\u00d710^\u221211]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "IRF7",
                "log ratio": "1.504",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "5.591"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[5.591, 2.88\u00d710^\u221210]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "FOXM1",
                "log ratio": "2.152",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "4.395"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[4.395, 5.12\u00d710^\u221210]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "STAT1",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "4.576"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[4.576, 2.05\u00d710^\u221208]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "ETS1",
                "log ratio": "0.863",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "2.575"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[2.575, 5.06\u00d710^\u221208]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "JUN",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "2.045"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[2.045, 5.57\u00d710^\u221208]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "FOXO1",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "3.242"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[3.242, 9.35\u00d710^\u221208]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "E2F3",
                "log ratio": "1.137",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "2.394"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[2.394, 1.16\u00d710^\u221206]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "MBD2",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": "2.549"
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[2.549, 5.41\u00d710^\u221206]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "upstream regulator": "Activation",
                "activation type": "activation",
                "statistical parameter": "Activation z-score",
                "statistical representation": ""
            },
            "measures": "[Activation z-score, P-value of overlap]",
            "outcomes": "[, ]"
        }
    ],
    "PMC3428781_1": [
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "characteristic": "Vitamin A lipid droplets",
                "status": "Present"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Vitamin A lipid droplets, Present]"
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "characteristic": "\u03b1 Smooth muscle actin",
                "status": "Absent"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[\u03b1 Smooth muscle actin, Absent]"
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "characteristic": "Proliferation",
                "status": "Limited"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Proliferation, Limited]"
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "characteristic": "Migration",
                "status": "Limited"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Migration, Limited]"
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "characteristic": "Extracellular matrix production",
                "status": "Limited"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Extracellular matrix production, Limited]"
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "characteristic": "Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix proteinases (TIMPs)",
                "status": "Complement of MMPs and TIMPs to maintain normal ECM turnover"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix proteinases (TIMPs), Complement of MMPs and TIMPs to maintain normal ECM turnover]"
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "characteristic": "Production of cytokines",
                "status": "Limited"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Production of cytokines, Limited]"
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "characteristic": "Capacity for phagocytosis",
                "status": "Absent"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Capacity for phagocytosis, Absent]"
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "characteristic": "Proteomic analyses",
                "status": "Basal protein expression"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Proteomic analyses, Basal protein expression]"
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "characteristic": "Vitamin A lipid droplets",
                "status": "Absent"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Vitamin A lipid droplets, Absent]"
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "characteristic": "\u03b1 Smooth muscle actin",
                "status": "Present"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[\u03b1 Smooth muscle actin, Present]"
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "characteristic": "Proliferation",
                "status": "Increased"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Proliferation, Increased]"
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "characteristic": "Migration",
                "status": "Increased"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Migration, Increased]"
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "characteristic": "Extracellular matrix production",
                "status": "Increased"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Extracellular matrix production, Increased]"
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "characteristic": "Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix proteinases (TIMPs)",
                "status": "Change in types of MMPs and TIMPs to facilitate ECM deposition"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix proteinases (TIMPs), Change in types of MMPs and TIMPs to facilitate ECM deposition]"
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "characteristic": "Production of cytokines",
                "status": "Increased (PDGF, TGF\u03b2, CTGF, IL1, IL6, IL15)"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Production of cytokines, Increased (PDGF, TGF\u03b2, CTGF, IL1, IL6, IL15)]"
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "characteristic": "Capacity for phagocytosis",
                "status": "Present"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Capacity for phagocytosis, Present]"
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "characteristic": "Proteomic analyses",
                "status": "Differential expression of proteins related to the cell cytoskeleton, cell metabolism, motility, growth and invasion"
            },
            "measures": "[characteristic, status]",
            "outcomes": "[Proteomic analyses, Differential expression of proteins related to the cell cytoskeleton, cell metabolism, motility, growth and invasion]"
        }
    ],
    "PMC4941331_3": [
        {
            "subject": {
                "analysis": "Association between nuclear HDAC3 and cytoplasmic CDH1 expression",
                "tissue sample": "Tumor tissue sample",
                "cytoplasmic CDH1 expression": "Low",
                "nuclear HDAC3 expression": "Low",
                "statistical representation": "Spearman correlation coefficient",
                "correlation coefficient": "0.440",
                "P-value": "< 0.001"
            },
            "measures": "[correlation coefficient, P-value]",
            "outcomes": "[0.440, < 0.001]"
        },
        {
            "subject": {
                "analysis": "Association between nuclear HDAC3 and cytoplasmic CDH1 expression",
                "tissue sample": "Tumor tissue sample",
                "cytoplasmic CDH1 expression": "High",
                "nuclear HDAC3 expression": "High",
                "statistical representation": "Spearman correlation coefficient",
                "correlation coefficient": "0.440",
                "P-value": "< 0.001"
            },
            "measures": "[correlation coefficient, P-value]",
            "outcomes": "[0.440, < 0.001]"
        }
    ],
    "PMC6062623_3": [
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Right",
                "density": "0.1",
                "statistical representation": "p-value"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.76, 0.002]"
        },
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Right",
                "density": "0.15",
                "statistical representation": "p-value"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.15, 0.008]"
        },
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Right",
                "density": "0.2",
                "statistical representation": "p-value"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.25, 0.006]"
        },
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Right",
                "density": "0.25",
                "statistical representation": "p-value"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.08, 0.009]"
        },
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Left",
                "density": "0.1",
                "statistical representation": "p-value"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-1.04, 0.32]"
        },
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Left",
                "density": "0.15",
                "statistical representation": "p-value"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-2.58, 0.022]"
        },
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Left",
                "density": "0.2",
                "statistical representation": "p-value"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.36, 0.005]"
        },
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Left",
                "density": "0.25",
                "statistical representation": "p-value"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.04, 0.01]"
        }
    ],
    "PMC5464866_2": [
        {
            "subject": {
                "analysis": "FXR expression analysis",
                "tissue type": "cancerous tissues",
                "technique": "immunohistochemistry",
                "study goal": "confirm the role of FXR in pancreatic cancer",
                "number of samples": "88",
                "FXR expression": "positive"
            },
            "measures": "[FXR expression percentage, P]",
            "outcomes": "[61.4%, < 0.05]"
        },
        {
            "subject": {
                "analysis": "FXR expression analysis",
                "tissue type": "cancerous tissues",
                "technique": "immunohistochemistry",
                "study goal": "confirm the role of FXR in pancreatic cancer",
                "number of samples": "88",
                "FXR expression": "negative"
            },
            "measures": "[FXR expression percentage, P]",
            "outcomes": "[38.6%, < 0.05]"
        },
        {
            "subject": {
                "analysis": "FXR expression analysis",
                "tissue type": "adjacent tissues",
                "technique": "immunohistochemistry",
                "study goal": "confirm the role of FXR in pancreatic cancer",
                "number of samples": "88",
                "FXR expression": "positive"
            },
            "measures": "[FXR expression percentage, P]",
            "outcomes": "[30.7%, < 0.05]"
        },
        {
            "subject": {
                "analysis": "FXR expression analysis",
                "tissue type": "adjacent tissues",
                "technique": "immunohistochemistry",
                "study goal": "confirm the role of FXR in pancreatic cancer",
                "number of samples": "88",
                "FXR expression": "negative"
            },
            "measures": "[FXR expression percentage, P]",
            "outcomes": "[69.3%, < 0.05]"
        }
    ],
    "PMC5687650_6": [
        {
            "subject": {
                "analysis": "Univariate and multivariate analysis of risk factors for the overall survival",
                "risk factor": "Gender",
                "category": "Women or Men",
                "type": "univariate analysis"
            },
            "measures": "[odds ratio (OR), P value]",
            "outcomes": "[0.770 (0.528-1.124), 0.175]"
        },
        {
            "subject": {
                "analysis": "Univariate and multivariate analysis of risk factors for the overall survival",
                "risk factor": "Age",
                "category": ">65 years or \u226465years",
                "type": "univariate analysis"
            },
            "measures": "[odds ratio (OR), P value]",
            "outcomes": "[0.773 (0.537-1.110), 0.163]"
        },
        {
            "subject": {
                "analysis": "Univariate and multivariate analysis of risk factors for the overall survival",
                "risk factor": "PLR",
                "category": "high or low",
                "type": "univariate analysis"
            },
            "measures": "[odds ratio (OR), P value]",
            "outcomes": "[0.922 (0.641-1.325), 0.660]"
        },
        {
            "subject": {
                "analysis": "Univariate and multivariate analysis of risk factors for the overall survival",
                "risk factor": "NLR",
                "category": "high or low",
                "type": "univariate analysis"
            },
            "measures": "[odds ratio (OR), P value]",
            "outcomes": "[1.007 (0.701-1.448), 0.969]"
        },
        {
            "subject": {
                "analysis": "Univariate and multivariate analysis of risk factors for the overall survival",
                "risk factor": "Post/pre-chemotherapy PLR ratio",
                "category": ">1 or \u22641",
                "type": "univariate analysis"
            },
            "measures": "[odds ratio (OR), P value]",
            "outcomes": "[1.272 (0.881-1.837), 0.199]"
        },
        {
            "subject": {
                "analysis": "Univariate and multivariate analysis of risk factors for the overall survival",
                "risk factor": "Post/pre-chemotherapy NLR ratio",
                "category": ">1 or \u22641",
                "type": "univariate analysis"
            },
            "measures": "[odds ratio (OR), P value]",
            "outcomes": "[1.902 (1.290-2.803), 0.001]"
        },
        {
            "subject": {
                "analysis": "Univariate and multivariate analysis of risk factors for the overall survival",
                "risk factor": "Post/pre-chemotherapy NLR ratio",
                "category": ">1 or \u22641",
                "type": "multivariate analysis"
            },
            "measures": "[odds ratio (OR), P value]",
            "outcomes": "[1.902 (1.290-2.803), 0.001]"
        }
    ],
    "PMC5464866_1": [
        {
            "subject": {
                "analysis": "survival data analysis",
                "cancer type": "pancreatic cancer",
                "expression": "FXR",
                "group": "Low",
                "year": "0",
                "number at risk": "87",
                "percentage": "49.7%"
            },
            "measures": "[number at risk]",
            "outcomes": "[87]"
        },
        {
            "subject": {
                "analysis": "survival data analysis",
                "cancer type": "pancreatic cancer",
                "expression": "FXR",
                "group": "Low",
                "year": "2",
                "number at risk": "16",
                "percentage": "9.1%"
            },
            "measures": "[number at risk]",
            "outcomes": "[16]"
        },
        {
            "subject": {
                "analysis": "survival data analysis",
                "cancer type": "pancreatic cancer",
                "expression": "FXR",
                "group": "Low",
                "year": "4",
                "number at risk": "6",
                "percentage": "3.4%"
            },
            "measures": "[number at risk]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "analysis": "survival data analysis",
                "cancer type": "pancreatic cancer",
                "expression": "FXR",
                "group": "Low",
                "year": "6",
                "number at risk": "1",
                "percentage": "0.6%"
            },
            "measures": "[number at risk]",
            "outcomes": "[1]"
        },
        {
            "subject": {
                "analysis": "survival data analysis",
                "cancer type": "pancreatic cancer",
                "expression": "FXR",
                "group": "High",
                "year": "0",
                "number at risk": "88",
                "percentage": "50.3%"
            },
            "measures": "[number at risk]",
            "outcomes": "[88]"
        },
        {
            "subject": {
                "analysis": "survival data analysis",
                "cancer type": "pancreatic cancer",
                "expression": "FXR",
                "group": "High",
                "year": "2",
                "number at risk": "9",
                "percentage": "5.1%"
            },
            "measures": "[number at risk]",
            "outcomes": "[9]"
        },
        {
            "subject": {
                "analysis": "survival data analysis",
                "cancer type": "pancreatic cancer",
                "expression": "FXR",
                "group": "High",
                "year": "4",
                "number at risk": "3",
                "percentage": "1.7%"
            },
            "measures": "[number at risk]",
            "outcomes": "[3]"
        },
        {
            "subject": {
                "analysis": "survival data analysis",
                "cancer type": "pancreatic cancer",
                "expression": "FXR",
                "group": "High",
                "year": "6",
                "number at risk": "0",
                "percentage": "0.0%"
            },
            "measures": "[number at risk]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "analysis": "survival data analysis",
                "cancer type": "pancreatic cancer",
                "expression": "FXR",
                "group": "Low",
                "metric": "median survival time",
                "unit": "year"
            },
            "measures": "[median survival time]",
            "outcomes": "[1.83]"
        },
        {
            "subject": {
                "analysis": "survival data analysis",
                "cancer type": "pancreatic cancer",
                "expression": "FXR",
                "group": "High",
                "metric": "median survival time",
                "unit": "year"
            },
            "measures": "[median survival time]",
            "outcomes": "[1.78]"
        },
        {
            "subject": {
                "analysis": "survival data analysis",
                "cancer type": "pancreatic cancer",
                "expression": "FXR",
                "group": "Low",
                "metric": "three year survival rate",
                "unit": "95% CI"
            },
            "measures": "[three year survival rate]",
            "outcomes": "[0.4288(0.3020~0.6089)]"
        },
        {
            "subject": {
                "analysis": "survival data analysis",
                "cancer type": "pancreatic cancer",
                "expression": "FXR",
                "group": "Low",
                "metric": "five year survival rate"
            },
            "measures": "[five year survival rate]",
            "outcomes": "[0.3127(0.1776~0.5503)]"
        },
        {
            "subject": {
                "analysis": "survival data analysis",
                "cancer type": "pancreatic cancer",
                "expression": "FXR",
                "group": "High",
                "metric": "three year survival rate",
                "unit": "95% CI"
            },
            "measures": "[three year survival rate]",
            "outcomes": "[0.3036(0.1646~0.5600)]"
        },
        {
            "subject": {
                "analysis": "survival data analysis",
                "cancer type": "pancreatic cancer",
                "expression": "FXR",
                "group": "High",
                "metric": "five year survival rate"
            },
            "measures": "[five year survival rate]",
            "outcomes": "[0.2277(0.0989~0.5241)]"
        }
    ],
    "PMC5641200_3": [
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Red blood cells count decreased",
                "dose level": "Level 1",
                "n": "6",
                "G1": "5 (83)",
                "G2": "1 (17)"
            },
            "measures": "[G1, G2]",
            "outcomes": "[5 (83), 1 (17)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Red blood cells count decreased",
                "dose level": "Level 2",
                "n": "4",
                "G1": "2 (50)",
                "G2": "0 (0)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[2 (50), 0 (0), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Leukopenia",
                "dose level": "Level 1",
                "n": "6",
                "G1": "3 (50)",
                "G2": "1 (17)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[3 (50), 1 (17), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Leukopenia",
                "dose level": "Level 2",
                "n": "4",
                "G1": "2 (50)",
                "G2": "1 (25)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[2 (50), 1 (25), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Neutropenia",
                "dose level": "Level 1",
                "n": "6",
                "G1": "4 (67)",
                "G2": "0 (0)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[4 (67), 0 (0), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Neutropenia",
                "dose level": "Level 2",
                "n": "4",
                "G1": "1 (25)",
                "G2": "1 (25)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[1 (25), 1 (25), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "AST increase",
                "dose level": "Level 1",
                "n": "6",
                "G1": "3 (50)",
                "G2": "0 (0)",
                "G3": "1 (17)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[3 (50), 0 (0), 1 (17)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "AST increase",
                "dose level": "Level 2",
                "n": "4",
                "G1": "4 (100)",
                "G2": "0 (0)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[4 (100), 0 (0), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "ALT increase",
                "dose level": "Level 1",
                "n": "6",
                "G1": "4 (67)",
                "G2": "1 (17)",
                "G3": "1 (17)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[4 (67), 1 (17), 1 (17)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "ALT increase",
                "dose level": "Level 2",
                "n": "4",
                "G1": "3 (75)",
                "G2": "0 (0)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[3 (75), 0 (0), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "GGT increase",
                "dose level": "Level 1",
                "n": "6",
                "G1": "1 (17)",
                "G2": "1 (17)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[1 (17), 1 (17), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "GGT increase",
                "dose level": "Level 2",
                "n": "4",
                "G1": "0 (0)",
                "G2": "0 (0)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[0 (0), 0 (0), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Hypocalcemia",
                "dose level": "Level 1",
                "n": "6",
                "G1": "1 (17)",
                "G2": "2 (33)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[1 (17), 2 (33), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Hypocalcemia",
                "dose level": "Level 2",
                "n": "4",
                "G1": "1 (25)",
                "G2": "1 (25)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[1 (25), 1 (25), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Hyponatremia",
                "dose level": "Level 1",
                "n": "6",
                "G1": "1 (17)",
                "G2": "0 (0)",
                "G3": "1 (17)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[1 (17), 0 (0), 1 (17)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Hyponatremia",
                "dose level": "Level 2",
                "n": "4",
                "G1": "0 (0)",
                "G2": "0 (0)",
                "G3": "1 (25)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[0 (0), 0 (0), 1 (25)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Nausea",
                "dose level": "Level 1",
                "n": "6",
                "G1": "3 (50)",
                "G2": "0 (0)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[3 (50), 0 (0), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Nausea",
                "dose level": "Level 2",
                "n": "4",
                "G1": "0 (0)",
                "G2": "2 (50)",
                "G3": "1 (25)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[0 (0), 2 (50), 1 (25)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Vomiting",
                "dose level": "Level 1",
                "n": "6",
                "G1": "2 (33)",
                "G2": "0 (0)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[2 (33), 0 (0), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Vomiting",
                "dose level": "Level 2",
                "n": "4",
                "G1": "0 (0)",
                "G2": "0 (0)",
                "G3": "1 (25)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[0 (0), 0 (0), 1 (25)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Diarrhea",
                "dose level": "Level 1",
                "n": "6",
                "G1": "0 (0)",
                "G2": "2 (33)",
                "G3": "2 (33)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[0 (0), 2 (33), 2 (33)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Diarrhea",
                "dose level": "Level 2",
                "n": "4",
                "G1": "1 (25)",
                "G2": "1 (25)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[1 (25), 1 (25), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Abdominal pain",
                "dose level": "Level 1",
                "n": "6",
                "G1": "1 (17)",
                "G2": "0 (0)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[1 (17), 0 (0), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Abdominal pain",
                "dose level": "Level 2",
                "n": "4",
                "G1": "0 (0)",
                "G2": "0 (0)",
                "G3": "1 (25)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[0 (0), 0 (0), 1 (25)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Oral mucositis",
                "dose level": "Level 1",
                "n": "6",
                "G1": "3 (50)",
                "G2": "0 (0)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[3 (50), 0 (0), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Oral mucositis",
                "dose level": "Level 2",
                "n": "4",
                "G1": "0 (0)",
                "G2": "0 (0)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[0 (0), 0 (0), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Dyspepsia",
                "dose level": "Level 1",
                "n": "6",
                "G1": "2 (33)",
                "G2": "0 (0)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[2 (33), 0 (0), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Dyspepsia",
                "dose level": "Level 2",
                "n": "4",
                "G1": "0 (0)",
                "G2": "0 (0)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[0 (0), 0 (0), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Dysgeusia",
                "dose level": "Level 1",
                "n": "6",
                "G1": "1 (17)",
                "G2": "0 (0)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[1 (17), 0 (0), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Dysgeusia",
                "dose level": "Level 2",
                "n": "4",
                "G1": "0 (0)",
                "G2": "1 (25)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[0 (0), 1 (25), 0 (0)]"
        },
        {
            "subject": {
                "analysis": "Treatment related adverse events by dose level",
                "adverse event": "Anorexia",
                "dose level": "Level 1",
                "n": "6",
                "G1": "3 (50)",
                "G2": "0 (0)",
                "G3": "0 (0)"
            },
            "measures": "[G1, G2, G3]",
            "outcomes": "[3 (50), 0 (0), 0 (0)]"
        }
    ],
    "PMC5716794_2": [
        {
            "subject": {
                "analysis": "ROC analysis",
                "disease": "healthy pancreas",
                "imaging modality": "diffusion-weighted imaging (DWI)",
                "quantitative measurement": "apparent diffusion coefficient (ADC) values",
                "ROI size (mm\u00b2)": "55",
                "optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "statistical representation": "mean \u00b1 SE (95% CI)"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.687 \u00b1 0.079, 89.1, 50.0, 86.4, 56.3, 80.5]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "disease": "healthy pancreas",
                "imaging modality": "diffusion-weighted imaging (DWI)",
                "quantitative measurement": "apparent diffusion coefficient (ADC) values",
                "ROI size (mm\u00b2)": "82",
                "optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.72",
                "statistical representation": "mean \u00b1 SE (95% CI)"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.694 \u00b1 0.077, 90.6, 50.0, 86.6, 59.9, 81.7]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "disease": "healthy pancreas",
                "imaging modality": "diffusion-weighted imaging (DWI)",
                "quantitative measurement": "apparent diffusion coefficient (ADC) values",
                "ROI size (mm\u00b2)": "99",
                "optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.73",
                "statistical representation": "mean \u00b1 SE (95% CI)"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.707 \u00b1 0.074, 90.6, 50.0, 86.6, 59.9, 81.7]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "disease": "healthy pancreas",
                "imaging modality": "diffusion-weighted imaging (DWI)",
                "quantitative measurement": "apparent diffusion coefficient (ADC) values",
                "ROI size (mm\u00b2)": "134",
                "optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.74",
                "statistical representation": "mean \u00b1 SE (95% CI)"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.731 \u00b1 0.070, 90.6, 50.0, 86.6, 59.9, 81.7]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "disease": "healthy pancreas",
                "imaging modality": "diffusion-weighted imaging (DWI)",
                "quantitative measurement": "apparent diffusion coefficient (ADC) values",
                "ROI size (mm\u00b2)": "152",
                "optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "statistical representation": "mean \u00b1 SE (95% CI)"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.751 \u00b1 0.067, 89.1, 55.6, 87.7, 58.9, 81.7]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "disease": "healthy pancreas",
                "imaging modality": "diffusion-weighted imaging (DWI)",
                "quantitative measurement": "apparent diffusion coefficient (ADC) values",
                "ROI size (mm\u00b2)": "161",
                "optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.70",
                "statistical representation": "mean \u00b1 SE (95% CI)"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.756 \u00b1 0.065, 89.1, 55.6, 87.7, 58.9, 81.7]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "disease": "healthy pancreas",
                "imaging modality": "diffusion-weighted imaging (DWI)",
                "quantitative measurement": "apparent diffusion coefficient (ADC) values",
                "ROI size (mm\u00b2)": "189",
                "optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.75",
                "statistical representation": "mean \u00b1 SE (95% CI)"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.770 \u00b1 0.062, 90.6, 55.6, 87.9, 62.5, 82.9]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "disease": "healthy pancreas",
                "imaging modality": "diffusion-weighted imaging (DWI)",
                "quantitative measurement": "apparent diffusion coefficient (ADC) values",
                "ROI size (mm\u00b2)": "214",
                "optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.79",
                "statistical representation": "mean \u00b1 SE (95% CI)"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.788 \u00b1 0.059, 92.2, 55.6, 88.1, 66.7, 84.2]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "disease": "healthy pancreas",
                "imaging modality": "diffusion-weighted imaging (DWI)",
                "quantitative measurement": "apparent diffusion coefficient (ADC) values",
                "ROI size (mm\u00b2)": "223",
                "optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.79",
                "statistical representation": "mean \u00b1 SE (95% CI)"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.793 \u00b1 0.058, 93.8, 55.6, 88.3, 71.6, 85.4]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "disease": "healthy pancreas",
                "imaging modality": "diffusion-weighted imaging (DWI)",
                "quantitative measurement": "apparent diffusion coefficient (ADC) values",
                "ROI size (mm\u00b2)": "245",
                "optimal cutoff values (\u00d7 10\u207b\u00b3mm\u00b2/s)": "1.79",
                "statistical representation": "mean \u00b1 SE (95% CI)"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.800 \u00b1 0.056, 95.3, 55.6, 88.4, 76.9, 86.6]"
        }
    ],
    "PMC3757392_2": [
        {
            "subject": {
                "vector": "C595:MUC1",
                "cell line": "Capan-1",
                "analysis": "Comparison of cell line properties",
                "ICC": "++",
                "Flow": "40",
                "Confocal": "++",
                "Do": "170"
            },
            "measures": "[ICC, Flow, Confocal, Do]",
            "outcomes": "[++, 40, ++, 170]"
        },
        {
            "subject": {
                "vector": "C595:MUC1",
                "cell line": "Cfpac-1",
                "analysis": "Comparison of cell line properties",
                "ICC": "+++",
                "Flow": "500",
                "Confocal": "+++",
                "Do": "140"
            },
            "measures": "[ICC, Flow, Confocal, Do]",
            "outcomes": "[+++, 500, +++, 140]"
        },
        {
            "subject": {
                "vector": "C595:MUC1",
                "cell line": "Panc-1",
                "analysis": "Comparison of cell line properties",
                "ICC": "+++",
                "Flow": "80",
                "Confocal": "+++",
                "Do": "160"
            },
            "measures": "[ICC, Flow, Confocal, Do]",
            "outcomes": "[+++, 80, +++, 160]"
        },
        {
            "subject": {
                "vector": "394:uPA",
                "cell line": "Capan-1",
                "analysis": "Comparison of cell line properties",
                "ICC": "++",
                "Flow": "88",
                "Confocal": "++",
                "Do": "190"
            },
            "measures": "[ICC, Flow, Confocal, Do]",
            "outcomes": "[++, 88, ++, 190]"
        },
        {
            "subject": {
                "vector": "394:uPA",
                "cell line": "Cfpac-1",
                "analysis": "Comparison of cell line properties",
                "ICC": "+++",
                "Flow": "92",
                "Confocal": "+++",
                "Do": "130"
            },
            "measures": "[ICC, Flow, Confocal, Do]",
            "outcomes": "[+++, 92, +++, 130]"
        },
        {
            "subject": {
                "vector": "394:uPA",
                "cell line": "Panc-1",
                "analysis": "Comparison of cell line properties",
                "ICC": "+++",
                "Flow": "91",
                "Confocal": "+++",
                "Do": "170"
            },
            "measures": "[ICC, Flow, Confocal, Do]",
            "outcomes": "[+++, 91, +++, 170]"
        },
        {
            "subject": {
                "vector": "2200-2500",
                "cell line": "all cells",
                "analysis": "Comparison of cell line properties",
                "Do": "2200-2500"
            },
            "measures": "[Do]",
            "outcomes": "[2200-2500]"
        }
    ]
}